(1->4)-beta-D-glucan multiple interactions ISO RGD:734269 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ANXA5 mRNA CTD PMID:36331819 (Z)-3-butylidenephthalide decreases expression ISO RGD:734268 6480464 butylidenephthalide results in decreased expression of ANXA5 protein CTD PMID:23770345 1,1-dichloroethene increases expression ISO RGD:734269 6480464 vinylidene chloride results in increased expression of ANXA5 mRNA CTD PMID:26682919 1,2-dimethylhydrazine multiple interactions ISO RGD:734269 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ANXA5 mRNA CTD PMID:22206623 1,3,5-trinitro-1,3,5-triazinane decreases expression EXP 6480464 cyclonite results in decreased expression of ANXA5 mRNA CTD PMID:25559034 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of ANXA5 mRNA CTD PMID:25380136 , PMID:30723492 17alpha-ethynylestradiol affects expression ISO RGD:734269 6480464 Ethinyl Estradiol affects the expression of ANXA5 mRNA CTD PMID:17555576 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of ANXA5 mRNA CTD PMID:12655037 17beta-estradiol multiple interactions ISO RGD:734268 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of ANXA5 mRNA CTD PMID:30165855 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:734269 6480464 2 more ... CTD PMID:30294300 2,2,2-tetramine multiple interactions EXP 6480464 Trientine inhibits the reaction [Streptozocin results in decreased expression of ANXA5 protein], Trientine inhibits the reaction [Streptozocin results in increased expression of ANXA5 protein] CTD PMID:19634143 , PMID:21136691 2,3',4,4',5-Pentachlorobiphenyl increases expression ISO RGD:734269 6480464 2 more ... CTD PMID:31388691 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:734269 6480464 Tetrachlorodibenzodioxin affects the expression of ANXA5 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of ANXA5 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of ANXA5 mRNA CTD PMID:20959002 2-hydroxypropanoic acid increases expression ISO RGD:734268 6480464 Lactic Acid results in increased expression of ANXA5 mRNA CTD PMID:30851411 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:20959002 3H-1,2-dithiole-3-thione decreases expression EXP 6480464 1, 2-dithiol-3-thione results in decreased expression of ANXA5 mRNA CTD PMID:19162173 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of ANXA5 mRNA CTD PMID:25380136 , PMID:30723492 4,4'-diaminodiphenylmethane decreases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of ANXA5 mRNA CTD PMID:18289764 4,4'-sulfonyldiphenol increases expression ISO RGD:734269 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of ANXA5 mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol increases expression ISO RGD:734268 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of ANXA5 protein CTD PMID:34186270 4,4'-sulfonyldiphenol affects expression ISO RGD:734268 6480464 bis(4-hydroxyphenyl)sulfone affects the expression of ANXA5 protein CTD PMID:31945527 5-aza-2'-deoxycytidine increases expression ISO RGD:734268 6480464 Decitabine results in increased expression of ANXA5 mRNA CTD PMID:16367923 5-aza-2'-deoxycytidine multiple interactions ISO RGD:734268 6480464 [Decitabine co-treated with Vorinostat] affects the expression of ANXA5 mRNA CTD PMID:17330099 9-cis-retinoic acid decreases expression ISO RGD:734268 6480464 Alitretinoin results in decreased expression of ANXA5 protein CTD PMID:28886987 acetamide increases expression EXP 6480464 acetamide results in increased expression of ANXA5 mRNA CTD PMID:31881176 acrylamide increases expression ISO RGD:734268 6480464 Acrylamide results in increased expression of ANXA5 protein CTD PMID:22543296 aflatoxin B1 increases expression ISO RGD:734269 6480464 Aflatoxin B1 results in increased expression of ANXA5 mRNA CTD PMID:19770486 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of ANXA5 mRNA CTD PMID:25378103 , PMID:33354967 aflatoxin B1 increases expression ISO RGD:734268 6480464 Aflatoxin B1 results in increased expression of ANXA5 mRNA CTD PMID:27153756 aflatoxin B1 decreases methylation ISO RGD:734268 6480464 Aflatoxin B1 results in decreased methylation of ANXA5 gene CTD PMID:27153756 aldehydo-D-glucose decreases expression ISO RGD:734268 6480464 Glucose results in decreased expression of ANXA5 mRNA CTD PMID:31655124 all-trans-retinoic acid increases expression ISO RGD:734268 6480464 Tretinoin results in increased expression of ANXA5 mRNA CTD PMID:15982314 , PMID:33167477 all-trans-retinoic acid multiple interactions ISO RGD:734268 6480464 Tretinoin promotes the reaction [tributyltin results in decreased expression of ANXA5 protein], Tretinoin promotes the reaction [triphenyltin chloride results in decreased expression of ANXA5 protein] CTD PMID:30806631 all-trans-retinoic acid multiple interactions ISO RGD:734269 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of ANXA5 mRNA CTD PMID:30951980 all-trans-retinoic acid decreases expression ISO RGD:734268 6480464 Tretinoin results in decreased expression of ANXA5 mRNA, Tretinoin results in decreased expression of ANXA5 protein CTD PMID:21934132 , PMID:28886987 all-trans-retinoic acid increases expression ISO RGD:734269 6480464 Tretinoin results in increased expression of ANXA5 mRNA CTD PMID:16604517 Allylamine increases expression EXP 6480464 Allylamine results in increased expression of ANXA5 mRNA CTD PMID:15910882 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of ANXA5 mRNA CTD PMID:16483693 amphibole asbestos increases expression ISO RGD:734268 6480464 Asbestos, Amphibole results in increased expression of ANXA5 protein CTD PMID:20855422 aristolochic acid A decreases expression ISO RGD:734268 6480464 aristolochic acid I results in decreased expression of ANXA5 protein CTD PMID:33212167 arsenite(3-) increases methylation ISO RGD:734268 6480464 arsenite results in increased methylation of ANXA5 promoter CTD PMID:23974009 asbestos increases expression ISO RGD:734268 6480464 Asbestos results in increased expression of ANXA5 mRNA CTD PMID:22398240 atrazine increases expression ISO RGD:734268 6480464 Atrazine results in increased expression of ANXA5 mRNA CTD PMID:22378314 atrazine decreases expression EXP 6480464 Atrazine results in decreased expression of ANXA5 mRNA CTD PMID:36841081 bacitracin increases expression EXP 6480464 Bacitracin results in increased expression of ANXA5 mRNA CTD PMID:18289764 benzatropine decreases expression ISO RGD:734268 6480464 Benztropine results in decreased expression of ANXA5 protein CTD PMID:34122009 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of ANXA5 mRNA CTD PMID:21839799 benzo[a]pyrene increases expression ISO RGD:734268 6480464 Benzo(a)pyrene results in increased expression of ANXA5 mRNA, Benzo(a)pyrene results in increased expression of ANXA5 protein CTD PMID:22581694 , PMID:32234424 beryllium sulfate increases expression ISO RGD:734268 6480464 beryllium sulfate results in increased expression of ANXA5 mRNA CTD PMID:16314022 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ANXA5 mRNA CTD PMID:18164116 bis(2-ethylhexyl) phthalate increases expression ISO RGD:734268 6480464 Diethylhexyl Phthalate results in increased expression of ANXA5 mRNA CTD PMID:31163220 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of ANXA5 mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:734268 6480464 bisphenol A results in decreased expression of ANXA5 protein CTD PMID:34186270 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ANXA5 mRNA CTD PMID:30816183 bisphenol A increases expression ISO RGD:734269 6480464 bisphenol A results in increased expression of ANXA5 mRNA CTD PMID:30951980 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of ANXA5 gene CTD PMID:28505145 bisphenol F increases expression ISO RGD:734269 6480464 bisphenol F results in increased expression of ANXA5 mRNA CTD PMID:30951980 bisphenol F increases expression ISO RGD:734268 6480464 bisphenol F results in increased expression of ANXA5 protein CTD PMID:34186270 bisphenol F multiple interactions ISO RGD:734269 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of ANXA5 mRNA CTD PMID:30951980 bleomycin A2 increases expression EXP 6480464 Bleomycin results in increased expression of ANXA5 protein CTD PMID:25933445 buspirone decreases expression EXP 6480464 Buspirone results in decreased expression of ANXA5 mRNA CTD PMID:24136188 cadmium dichloride increases expression ISO RGD:734268 6480464 Cadmium Chloride results in increased expression of ANXA5 protein CTD PMID:24527689 calcium atom multiple interactions ISO RGD:734268 6480464 Calcium binds to and results in increased activity of ANXA5 protein, Calcium promotes the reaction [Phosphatidylserines binds to ANXA5 protein] CTD PMID:11578147 , PMID:16076491 calcium(0) multiple interactions ISO RGD:734268 6480464 Calcium binds to and results in increased activity of ANXA5 protein, Calcium promotes the reaction [Phosphatidylserines binds to ANXA5 protein] CTD PMID:11578147 , PMID:16076491 carbamazepine affects expression ISO RGD:734268 6480464 Carbamazepine affects the expression of ANXA5 mRNA CTD PMID:25979313 carbon nanotube affects expression ISO RGD:734268 6480464 Nanotubes, Carbon affects the expression of ANXA5 protein CTD PMID:22001959 carbon nanotube affects expression ISO RGD:734269 6480464 Nanotubes, Carbon affects the expression of ANXA5 protein CTD PMID:21135415 carbon nanotube decreases expression ISO RGD:734269 6480464 Nanotubes more ... CTD PMID:25620056 carbon nanotube increases expression ISO RGD:734268 6480464 Nanotubes, Carbon results in increased expression of ANXA5 protein CTD PMID:22157353 CGP 52608 multiple interactions ISO RGD:734268 6480464 CGP 52608 promotes the reaction [RORA protein binds to ANXA5 gene] CTD PMID:28238834 chlordecone increases expression ISO RGD:734269 6480464 Chlordecone results in increased expression of ANXA5 mRNA CTD PMID:33711761 chloropicrin increases expression ISO RGD:734268 6480464 chloropicrin results in increased expression of ANXA5 mRNA CTD PMID:26352163 chlorpyrifos increases cleavage ISO RGD:734268 6480464 Chlorpyrifos results in increased cleavage of ANXA5 protein CTD PMID:24793810 chlorpyrifos increases expression ISO RGD:734269 6480464 Chlorpyrifos results in increased expression of ANXA5 mRNA CTD PMID:37019170 choline multiple interactions ISO RGD:734269 6480464 [Dietary Fats co-treated with Choline deficiency] results in increased expression of ANXA5 mRNA more ... CTD PMID:20938992 , PMID:29246445 cisplatin decreases expression ISO RGD:734268 6480464 Cisplatin results in decreased expression of ANXA5 protein CTD PMID:21924258 cisplatin multiple interactions ISO RGD:734268 6480464 Cisplatin promotes the reaction [jinfukang results in decreased expression of ANXA5 mRNA], jinfukang promotes the reaction [Cisplatin results in decreased expression of ANXA5 mRNA] CTD PMID:27392435 cisplatin increases expression ISO RGD:734268 6480464 Cisplatin results in increased expression of ANXA5 mRNA CTD PMID:27594783 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of ANXA5 mRNA CTD PMID:18289764 clofibrate multiple interactions ISO RGD:734269 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of ANXA5 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ANXA5 mRNA] CTD PMID:17585979 clozapine decreases expression ISO RGD:734268 6480464 Clozapine results in decreased expression of ANXA5 protein CTD PMID:34122009 cobalt atom increases expression ISO RGD:734269 6480464 Cobalt results in increased expression of ANXA5 mRNA CTD PMID:22147119 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of ANXA5 protein CTD PMID:24386269 copper atom affects binding ISO RGD:734268 6480464 ANXA5 protein binds to Copper CTD PMID:15359738 copper atom decreases expression EXP 6480464 Copper results in decreased expression of ANXA5 mRNA CTD PMID:30556269 copper atom multiple interactions ISO RGD:734269 6480464 MT1 affects the reaction [Copper results in increased expression of ANXA5 mRNA], MT2 affects the reaction [Copper results in increased expression of ANXA5 mRNA] CTD PMID:16629173 copper(0) affects binding ISO RGD:734268 6480464 ANXA5 protein binds to Copper CTD PMID:15359738 copper(0) decreases expression EXP 6480464 Copper results in decreased expression of ANXA5 mRNA CTD PMID:30556269 copper(0) multiple interactions ISO RGD:734269 6480464 MT1 affects the reaction [Copper results in increased expression of ANXA5 mRNA], MT2 affects the reaction [Copper results in increased expression of ANXA5 mRNA] CTD PMID:16629173 copper(II) sulfate increases expression ISO RGD:734268 6480464 Copper Sulfate results in increased expression of ANXA5 mRNA CTD PMID:19549813 crocidolite asbestos decreases expression ISO RGD:734269 6480464 Asbestos, Crocidolite results in decreased expression of ANXA5 mRNA CTD PMID:29279043 crocidolite asbestos increases expression ISO RGD:734268 6480464 Asbestos, Crocidolite results in increased expression of ANXA5 protein CTD PMID:29553831 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of ANXA5 mRNA CTD PMID:26577399 cyclosporin A increases expression ISO RGD:734268 6480464 Cyclosporine results in increased expression of ANXA5 mRNA CTD PMID:20106945 , PMID:25562108 D-glucose decreases expression ISO RGD:734268 6480464 Glucose results in decreased expression of ANXA5 mRNA CTD PMID:31655124 Destruxin B increases expression ISO RGD:734268 6480464 destruxin B results in increased expression of ANXA5 protein CTD PMID:22465936 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of ANXA5 mRNA CTD PMID:21266533 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of ANXA5 mRNA CTD PMID:17379624 dibutyl phthalate increases expression ISO RGD:734269 6480464 Dibutyl Phthalate results in increased expression of ANXA5 mRNA CTD PMID:17361019 , PMID:21266533 dichlorine multiple interactions EXP 6480464 [Ozone co-treated with Chlorine] results in decreased expression of ANXA5 mRNA CTD PMID:18636392 dorsomorphin multiple interactions ISO RGD:734268 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin multiple interactions EXP 6480464 THPO protein inhibits the reaction [Doxorubicin results in increased expression of ANXA5 protein] CTD PMID:16651473 doxorubicin increases oxidation EXP 6480464 Doxorubicin results in increased oxidation of ANXA5 protein CTD PMID:28818578 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of ANXA5 protein CTD PMID:16651473 entinostat increases expression ISO RGD:734268 6480464 entinostat results in increased expression of ANXA5 mRNA CTD PMID:27188386 enzyme inhibitor multiple interactions ISO RGD:734268 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of ANXA5 protein CTD PMID:23301498 fenthion increases expression ISO RGD:734269 6480464 Fenthion results in increased expression of ANXA5 mRNA CTD PMID:34813904 fentin chloride decreases expression ISO RGD:734268 6480464 triphenyltin chloride results in decreased expression of ANXA5 protein CTD PMID:30806631 fentin chloride multiple interactions ISO RGD:734268 6480464 Tretinoin promotes the reaction [triphenyltin chloride results in decreased expression of ANXA5 protein] CTD PMID:30806631 fluoxetine multiple interactions ISO RGD:734268 6480464 Fluoxetine promotes the reaction [Phosphatidylserines binds to ANXA5 protein] CTD PMID:16076491 fluoxetine affects expression EXP 6480464 Fluoxetine affects the expression of ANXA5 mRNA CTD PMID:21852994 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of ANXA5 mRNA CTD PMID:24793618 folic acid multiple interactions ISO RGD:734269 6480464 [1 more ... CTD PMID:20938992 , PMID:22206623 fumonisin B1 increases expression ISO RGD:734269 6480464 fumonisin B1 results in increased expression of ANXA5 mRNA CTD PMID:16221962 furan increases expression EXP 6480464 furan results in increased expression of ANXA5 mRNA CTD PMID:15120968 more ... furan decreases methylation EXP 6480464 furan results in decreased methylation of ANXA5 gene CTD PMID:27387713 genistein increases expression EXP 6480464 Genistein results in increased expression of ANXA5 mRNA CTD PMID:21782745 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of ANXA5 mRNA CTD PMID:22061828 , PMID:33387578 glucose decreases expression ISO RGD:734268 6480464 Glucose results in decreased expression of ANXA5 mRNA CTD PMID:31655124 glycidyl methacrylate increases expression ISO RGD:734268 6480464 glycidyl methacrylate results in increased expression of ANXA5 protein CTD PMID:36641056 gold atom increases expression ISO RGD:734269 6480464 Gold analog results in increased expression of ANXA5 protein CTD PMID:24780912 gold(0) increases expression ISO RGD:734269 6480464 Gold analog results in increased expression of ANXA5 protein CTD PMID:24780912 graphite increases expression ISO RGD:734268 6480464 Graphite results in increased expression of ANXA5 protein CTD PMID:22157353 griseofulvin increases expression ISO RGD:734269 6480464 Griseofulvin results in increased expression of ANXA5 mRNA CTD PMID:12735108 hyaluronic acid decreases expression EXP 6480464 Hyaluronic Acid analog results in decreased expression of ANXA5 protein CTD PMID:23178681 hyaluronic acid multiple interactions EXP 6480464 Hyaluronic Acid analog inhibits the reaction [Hydrogen Peroxide results in decreased expression of ANXA5 protein] CTD PMID:23178681 hydrazine increases expression ISO RGD:734269 6480464 hydrazine results in increased expression of ANXA5 mRNA CTD PMID:15282401 hydrogen peroxide multiple interactions EXP 6480464 Hyaluronic Acid analog inhibits the reaction [Hydrogen Peroxide results in decreased expression of ANXA5 protein] CTD PMID:23178681 hydrogen peroxide increases expression ISO RGD:734268 6480464 Hydrogen Peroxide results in increased expression of ANXA5 protein CTD PMID:34581912 hydrogen peroxide decreases expression EXP 6480464 Hydrogen Peroxide results in decreased expression of ANXA5 protein CTD PMID:23178681 indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of ANXA5 mRNA CTD PMID:21396975 indometacin increases expression ISO RGD:734268 6480464 Indomethacin results in increased expression of ANXA5 protein CTD PMID:18678619 isoflavones multiple interactions EXP 6480464 [ENNG co-treated with Isoflavones] results in increased expression of ANXA5 protein CTD PMID:22248470 ivermectin decreases expression ISO RGD:734268 6480464 Ivermectin results in decreased expression of ANXA5 protein CTD PMID:32959892 ketamine decreases expression EXP 6480464 Ketamine results in decreased expression of ANXA5 mRNA CTD PMID:20080153 kojic acid multiple interactions ISO RGD:734269 6480464 [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of ANXA5 mRNA CTD PMID:17917374 L-ascorbic acid multiple interactions ISO RGD:734269 6480464 [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of ANXA5 mRNA CTD PMID:17917374 L-ascorbic acid increases expression EXP 6480464 Ascorbic Acid results in increased expression of ANXA5 mRNA CTD PMID:15372504 L-ascorbic acid increases expression ISO RGD:734269 6480464 Ascorbic Acid results in increased expression of ANXA5 protein CTD PMID:19224539 L-methionine multiple interactions ISO RGD:734269 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ANXA5 mRNA CTD PMID:20938992 lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of ANXA5 mRNA, lead acetate results in increased expression of ANXA5 protein CTD PMID:11578147 lead diacetate multiple interactions ISO RGD:734268 6480464 lead acetate binds to and results in increased activity of ANXA5 protein CTD PMID:11578147 lead(0) affects expression ISO RGD:734268 6480464 Lead affects the expression of ANXA5 mRNA CTD PMID:28903495 lipopolysaccharide multiple interactions ISO RGD:734269 6480464 Indirubin E804 inhibits the reaction [Lipopolysaccharides results in increased expression of ANXA5 mRNA], Lipopolysaccharides inhibits the reaction [Indirubin E804 results in increased expression of ANXA5 mRNA] CTD PMID:23107598 lipopolysaccharide increases expression ISO RGD:734269 6480464 Lipopolysaccharides results in increased expression of ANXA5 mRNA CTD PMID:23107598 lipopolysaccharide decreases expression ISO RGD:734268 6480464 Lipopolysaccharides results in decreased expression of ANXA5 mRNA CTD PMID:22777745 lithium atom increases expression EXP 6480464 Lithium results in increased expression of ANXA5 protein CTD PMID:18296634 lithium hydride increases expression EXP 6480464 Lithium results in increased expression of ANXA5 protein CTD PMID:18296634 lithocholic acid increases expression ISO RGD:734269 6480464 Lithocholic Acid results in increased expression of ANXA5 mRNA CTD PMID:20359477 lithocholic acid multiple interactions ISO RGD:734269 6480464 Pregnenolone Carbonitrile inhibits the reaction [Lithocholic Acid results in increased expression of ANXA5 mRNA] CTD PMID:20359477 lovastatin decreases expression ISO RGD:734269 6480464 Lovastatin results in decreased expression of ANXA5 mRNA CTD PMID:20493250 mercury dichloride multiple interactions ISO RGD:734268 6480464 ANXA5 protein inhibits the reaction [Mercuric Chloride results in increased activity of F3 protein] CTD PMID:17726162 methidathion increases expression ISO RGD:734269 6480464 methidathion results in increased expression of ANXA5 mRNA CTD PMID:34813904 microcystin-LR increases expression ISO RGD:734269 6480464 cyanoginosin LR results in increased expression of ANXA5 mRNA CTD PMID:17654400 Monobutylphthalate increases expression ISO RGD:734269 6480464 monobutyl phthalate results in increased expression of ANXA5 protein CTD PMID:20553848 monocrotaline multiple interactions ISO RGD:734269 6480464 [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of ANXA5 mRNA CTD PMID:21224054 Myrtucommulone A decreases expression ISO RGD:734269 6480464 myrtucommulone A results in decreased expression of ANXA5 mRNA CTD PMID:26032814 N,N-diethyl-m-toluamide multiple interactions ISO RGD:734268 6480464 [DEET affects the localization of Phosphatidylserines] promotes the reaction [ANXA5 protein binds to Phosphatidylserines], DEET promotes the reaction [ANXA5 protein binds to Phosphatidylserines] CTD PMID:30880218 N-acetyl-L-cysteine multiple interactions ISO RGD:734268 6480464 Acetylcysteine inhibits the reaction [Sodium Fluoride results in increased expression of ANXA5 protein], Acetylcysteine inhibits the reaction [Tin Fluorides results in increased expression of ANXA5 protein] CTD PMID:22093110 N-methyl-N'-nitro-N-nitrosoguanidine multiple interactions ISO RGD:734269 6480464 [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of ANXA5 mRNA CTD PMID:19840844 N-nitrosodiethylamine multiple interactions ISO RGD:734269 6480464 [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of ANXA5 mRNA CTD PMID:17917374 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of ANXA5 mRNA, Diethylnitrosamine results in increased expression of ANXA5 protein CTD PMID:19638242 , PMID:20935162 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ANXA5 mRNA more ... CTD PMID:18164116 more ... N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of ANXA5 mRNA CTD PMID:25380136 N-nitrosomorpholine increases expression EXP 6480464 N-nitrosomorpholine results in increased expression of ANXA5 protein CTD PMID:15816005 naphthalene decreases reduction ISO RGD:734269 6480464 naphthalene results in decreased reduction of ANXA5 protein CTD PMID:19843705 nefazodone decreases expression EXP 6480464 nefazodone results in decreased expression of ANXA5 mRNA CTD PMID:24136188 nimesulide decreases expression EXP 6480464 nimesulide results in decreased expression of ANXA5 mRNA CTD PMID:24136188 nitric oxide increases expression ISO RGD:734268 6480464 Nitric Oxide results in increased expression of ANXA5 protein CTD PMID:16024610 okadaic acid multiple interactions ISO RGD:734269 6480464 [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of ANXA5 mRNA CTD PMID:19840844 orphenadrine affects expression EXP 6480464 Orphenadrine affects the expression of ANXA5 mRNA CTD PMID:23665939 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of ANXA5 mRNA CTD PMID:25729387 ozone multiple interactions EXP 6480464 [Ozone co-treated with Chlorine] results in decreased expression of ANXA5 mRNA CTD PMID:18636392 p-menthan-3-ol increases expression ISO RGD:734268 6480464 Menthol results in increased expression of ANXA5 protein CTD PMID:26760959 paracetamol multiple interactions ISO RGD:734269 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of ANXA5 mRNA more ... CTD PMID:17585979 , PMID:29246445 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of ANXA5 mRNA CTD PMID:33387578 paracetamol increases expression ISO RGD:734269 6480464 Acetaminophen results in increased expression of ANXA5 mRNA CTD PMID:29246445 paracetamol increases expression ISO RGD:734268 6480464 Acetaminophen results in increased expression of ANXA5 mRNA CTD PMID:29067470 paracetamol affects expression ISO RGD:734269 6480464 Acetaminophen affects the expression of ANXA5 mRNA CTD PMID:17562736 paraquat increases expression ISO RGD:734268 6480464 Paraquat results in increased expression of ANXA5 mRNA CTD PMID:20883675 paraquat increases expression EXP 6480464 Paraquat results in increased expression of ANXA5 mRNA CTD PMID:32680482 perfluorooctane-1-sulfonic acid decreases expression EXP 6480464 perfluorooctane sulfonic acid results in decreased expression of ANXA5 mRNA CTD PMID:18692542 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:734269 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ANXA5 mRNA, [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of ANXA5 mRNA CTD PMID:36331819 perfluorooctanoic acid decreases expression ISO RGD:734269 6480464 perfluorooctanoic acid results in decreased expression of ANXA5 protein CTD PMID:28126411 perfluorooctanoic acid increases expression ISO RGD:734268 6480464 perfluorooctanoic acid results in increased expression of ANXA5 protein CTD PMID:26879310 phenobarbital multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of ANXA5 protein CTD PMID:20935162 phenylmercury acetate increases expression ISO RGD:734268 6480464 Phenylmercuric Acetate results in increased expression of ANXA5 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:734268 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANXA5 mRNA CTD PMID:27188386 phenytoin multiple interactions ISO RGD:734269 6480464 [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of ANXA5 mRNA CTD PMID:21224054 picoxystrobin increases expression ISO RGD:734268 6480464 picoxystrobin results in increased expression of ANXA5 mRNA CTD PMID:33512557 pirinixic acid multiple interactions ISO RGD:734269 6480464 PPARA protein promotes the reaction [pirinixic acid results in increased expression of ANXA5 mRNA] CTD PMID:20059764 pirinixic acid increases expression ISO RGD:734269 6480464 pirinixic acid results in increased expression of ANXA5 mRNA CTD PMID:18301758 more ... pregnenolone 16alpha-carbonitrile multiple interactions ISO RGD:734269 6480464 Pregnenolone Carbonitrile inhibits the reaction [Lithocholic Acid results in increased expression of ANXA5 mRNA] CTD PMID:20359477 Ptaquiloside affects expression ISO RGD:734268 6480464 ptaquiloside affects the expression of ANXA5 protein CTD PMID:22143989 quartz increases expression ISO RGD:734269 6480464 Quartz results in increased expression of ANXA5 protein CTD PMID:20085295 quercetin multiple interactions ISO RGD:734268 6480464 [Quercetin co-treated with TNFSF10 protein] results in increased expression of ANXA5 protein CTD PMID:18377872 rac-lactic acid increases expression ISO RGD:734268 6480464 Lactic Acid results in increased expression of ANXA5 mRNA CTD PMID:30851411 resveratrol increases expression ISO RGD:734268 6480464 resveratrol results in increased expression of ANXA5 protein CTD PMID:12060119 rifampicin multiple interactions ISO RGD:734269 6480464 [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of ANXA5 mRNA CTD PMID:21224054 rotenone increases expression ISO RGD:734269 6480464 Rotenone results in increased expression of ANXA5 mRNA CTD PMID:23186747 rotenone increases expression ISO RGD:734268 6480464 Rotenone results in increased expression of ANXA5 mRNA CTD PMID:33512557 ruthenium atom increases expression ISO RGD:734268 6480464 Ruthenium results in increased expression of ANXA5 protein CTD PMID:17210701 Salinomycin decreases expression ISO RGD:734268 6480464 salinomycin results in decreased expression of ANXA5 mRNA CTD PMID:19682730 SB 431542 multiple interactions ISO RGD:734268 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 sodium arsenite increases expression ISO RGD:734268 6480464 sodium arsenite results in increased expression of ANXA5 protein CTD PMID:24100277 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of ANXA5 protein CTD PMID:29459688 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of ANXA5 mRNA CTD PMID:22561333 sodium fluoride decreases expression ISO RGD:734269 6480464 Sodium Fluoride results in decreased expression of ANXA5 protein CTD PMID:27548804 , PMID:28918527 sodium fluoride increases expression ISO RGD:734268 6480464 Sodium Fluoride results in increased expression of ANXA5 protein CTD PMID:22093110 sodium fluoride multiple interactions ISO RGD:734268 6480464 Acetylcysteine inhibits the reaction [Sodium Fluoride results in increased expression of ANXA5 protein] CTD PMID:22093110 Sodium salicylate increases activity ISO RGD:734268 6480464 Sodium Salicylate results in increased activity of ANXA5 protein CTD PMID:10090950 Soman increases expression EXP 6480464 Soman results in increased expression of ANXA5 mRNA CTD PMID:19281266 streptozocin multiple interactions EXP 6480464 Trientine inhibits the reaction [Streptozocin results in decreased expression of ANXA5 protein], Trientine inhibits the reaction [Streptozocin results in increased expression of ANXA5 protein] CTD PMID:19634143 , PMID:21136691 streptozocin decreases expression EXP 6480464 Streptozocin results in decreased expression of ANXA5 protein CTD PMID:19634143 streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of ANXA5 protein CTD PMID:21136691 sulindac sulfide increases expression ISO RGD:734268 6480464 sulindac sulfide results in increased expression of ANXA5 protein CTD PMID:18678619 T-2 toxin affects expression EXP 6480464 T-2 Toxin affects the expression of ANXA5 protein CTD PMID:26141394 tetrachloromethane increases expression ISO RGD:734269 6480464 Carbon Tetrachloride results in increased expression of ANXA5 mRNA CTD PMID:27339419 more ... tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of ANXA5 mRNA CTD PMID:31150632 thapsigargin increases expression ISO RGD:734268 6480464 Thapsigargin results in increased expression of ANXA5 mRNA CTD PMID:22378314 thapsigargin increases expression EXP 6480464 Thapsigargin results in increased expression of ANXA5 protein CTD PMID:35544339 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of ANXA5 mRNA CTD PMID:23411599 , PMID:34492290 thioacetamide multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of ANXA5 mRNA CTD PMID:28943392 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of ANXA5 mRNA CTD PMID:25729387 topotecan increases expression EXP 6480464 Topotecan results in increased expression of ANXA5 mRNA CTD PMID:25729387 tributylstannane decreases expression ISO RGD:734268 6480464 tributyltin results in decreased expression of ANXA5 protein CTD PMID:30806631 tributylstannane multiple interactions ISO RGD:734268 6480464 Tretinoin promotes the reaction [tributyltin results in decreased expression of ANXA5 protein] CTD PMID:30806631 trichloroethene increases methylation EXP 6480464 Trichloroethylene results in increased methylation of ANXA5 gene CTD PMID:27618143 triphenylstannane decreases expression ISO RGD:734268 6480464 triphenyltin analog results in decreased expression of ANXA5 protein CTD PMID:31634547 troglitazone increases expression ISO RGD:734268 6480464 troglitazone results in increased expression of ANXA5 mRNA CTD PMID:19631733 valproic acid affects expression ISO RGD:734268 6480464 Valproic Acid affects the expression of ANXA5 mRNA CTD PMID:25979313 valproic acid increases expression ISO RGD:734268 6480464 Valproic Acid results in increased expression of ANXA5 mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO RGD:734268 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANXA5 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:734269 6480464 Valproic Acid results in increased expression of ANXA5 mRNA CTD PMID:15345369 more ... valproic acid decreases methylation ISO RGD:734268 6480464 Valproic Acid results in decreased methylation of ANXA5 gene CTD PMID:29154799 vancomycin decreases expression ISO RGD:734269 6480464 Vancomycin results in decreased expression of ANXA5 mRNA CTD PMID:18930951 vancomycin increases expression EXP 6480464 Vancomycin results in increased expression of ANXA5 mRNA CTD PMID:18289764 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of ANXA5 mRNA CTD PMID:19015723 vorinostat multiple interactions ISO RGD:734268 6480464 [decitabine co-treated with vorinostat] affects the expression of ANXA5 mRNA CTD PMID:17330099 warfarin decreases expression ISO RGD:734269 6480464 Warfarin results in decreased expression of ANXA5 mRNA CTD PMID:20493250 zearalenone affects binding ISO RGD:734269 6480464 Zearalenone binds to ANXA5 protein CTD PMID:24412631 zinc pyrithione increases expression ISO RGD:734268 6480464 pyrithione zinc results in increased expression of ANXA5 mRNA CTD PMID:21424779